Category Archives: Drug Industry Daily

FDA Drug and Device Approvals — May 2023

By | Drug Industry Daily | No Comments

New FDA drug approvals in May include the first vaccine for respiratory syncytial virus, a hot flash treatment for menopausal women, a gene therapy for a rare skin disease and the first and only treatment for a rare hematologic disorder. Additionally, the FDA approved a next-generation sequencing-based companion diagnostic test for solid tumor profiling.
Source: Drug Industry Daily